As a follow-up to our last “big 3” comparison, Psychedelic Invest’s very own Adam Tubero provides an updated comparative analysis of Mind Medicine ($MNMD), atai Life Sciences ($ATAI), and Compass Pathways ($CMPS).

In the below video, Adam provides a deep dive comparing the financials and the pipelines of these three companies. All of the information used is current as of each company’s Q1 2022 earnings reports.

For more videos like this, check out the Psychedelic Invest YouTube channel.